RecruitingNot ApplicableNCT04603859

When to INDuce for OverWeight? (WINDOW)

When to INDuce for OverWeight? - a Randomised Controlled Trial (WINDOW)


Sponsor

University of Aarhus

Enrollment

1,900 participants

Start Date

Oct 19, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The rate of overweight and obese women becoming pregnant is increasing. Obesity in pregnancy along with delivery by cesarean section in obese women is associated with several complications as compared to normal weight women. The longer the woman is pregnant, the longer she is at risk. In an otherwise low-risk pregnant woman at term, it is an ongoing clinical dilemma, whether the benefits of elective induction of labor and termination of the pregnancy will outweigh the potential harms from concomitant induction and delivery process. The proposed study is a randomized controlled study of elective induction versus expectant management in obese women. The study will be carried out as a national multicenter study with inclusion of 1900 participants from Danish delivery wards. The null hypothesis is that the caesarean section rate is similar with elective induction of labor at 39 weeks of gestation, compared with expectant management among pregnant women with pre- or early pregnancy BMI≥30.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria1

  • Pregnant women with pre- or early pregnancy BMI ≥ 30 kg/m2

Exclusion Criteria9

  • Legal or ethical considerations: maternal age <18 years, language difficulties requiring an interpreter or translator
  • Multiple pregnancy
  • Previous caesarean section
  • Uncertain gestational age, defined as gestational age determined by other measurements than the Crown-Rump length (CRL) Measurement
  • Planned elective caesarean section at time of randomisation
  • Fetal contraindications to IOL at time of randomisation: e.g. non-cephalic presentation, or other fetal conditions contraindicating vaginal delivery
  • Fetal contraindications to expectant management at time of randomisation
  • Maternal contraindications to IOL at time of randomisation: e.g. placenta previa/accreta, vasa previa
  • Maternal contraindications to expectant management at time of randomisation: e.g. maternal medical conditions, ultrasonically diagnosed oligohydramnios (DVP< 2 cm), signs of labour including pre-labour rupture of membranes (PROM)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREElective induction of labor at 39 gestational weeks and 0 to 3 days

Elective induction of labor (eIOL) according to local policies


Locations(12)

Aarhus University Hospital

Aarhus, Denmark

Rigshospitalet Juliane Marie Centre

Copenhagen, Denmark

Herlev Hospital

Herlev, Denmark

Gødstrup Regional Hospital

Herning, Denmark

North Zealand's Hospital

Hillerød, Denmark

Hvidovre Hospital

Hvidovre, Denmark

Kolding Hospital

Kolding, Denmark

Nykøbing Falster Hospital

Nykøbing Falster, Denmark

Odense University Hospital

Odense, Denmark

Randers Regional Hospital

Randers, Denmark

Zealand University Hospital

Roskilde, Denmark

Viborg Hospital

Viborg, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04603859


Related Trials